Arkolith/Insider Trading/OCX/Form 4

Broadwood Capital Inc

10% OwnerOncocyte Corp (OCX) · full profile →Form 4 · filed Oct 4, 2024
Net Buying
Open-Market Buys
$3.9M
Open-Market Sells
$0
Net Open-Market Flow
$3.9M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 2, 2024Buy(P)0—$06.2M
Oct 2, 2024Buy(P)1.3M$2.95$3.9M6.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000919574-24-005764) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML